Role of Neoplastic Markers in Pancreatic Adenocarcinoma

J Clin Med. 2022 Nov 2;11(21):6509. doi: 10.3390/jcm11216509.

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is considered one of the "Big Five" lethal cancers, which include lung, bowel, breast and prostate cancer [...].

Publication types

  • Editorial

Grants and funding

This research received no external funding.